Editas Medicine, Inc. (EDIT)
2.475
-0.18
(-6.60%)
USD |
NASDAQ |
Jun 10, 16:00
2.54
+0.06
(+2.63%)
After-Hours: 20:00
Editas Medicine 1 Year Total Returns (Daily) : 37.31% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 37.31% |
| June 08, 2026 | 38.48% |
| June 05, 2026 | 50.56% |
| June 04, 2026 | 64.29% |
| June 03, 2026 | 52.75% |
| June 02, 2026 | 59.32% |
| June 01, 2026 | 94.19% |
| May 29, 2026 | 89.07% |
| May 28, 2026 | 83.42% |
| May 27, 2026 | 116.4% |
| May 26, 2026 | 98.71% |
| May 22, 2026 | 70.37% |
| May 21, 2026 | 78.00% |
| May 20, 2026 | 58.54% |
| May 19, 2026 | 65.10% |
| May 18, 2026 | 67.55% |
| May 15, 2026 | 87.81% |
| May 14, 2026 | 106.5% |
| May 13, 2026 | 93.33% |
| May 12, 2026 | 90.26% |
| May 11, 2026 | 111.0% |
| May 08, 2026 | 123.7% |
| May 07, 2026 | 127.8% |
| May 06, 2026 | 138.7% |
| May 05, 2026 | 97.40% |
| Date | Value |
|---|---|
| May 04, 2026 | 82.93% |
| May 01, 2026 | 79.01% |
| April 30, 2026 | 81.82% |
| April 29, 2026 | 81.94% |
| April 28, 2026 | 93.67% |
| April 27, 2026 | 87.66% |
| April 24, 2026 | 80.75% |
| April 23, 2026 | 105.8% |
| April 22, 2026 | 113.5% |
| April 21, 2026 | 148.1% |
| April 20, 2026 | 178.9% |
| April 17, 2026 | 172.7% |
| April 16, 2026 | 163.8% |
| April 15, 2026 | 149.6% |
| April 14, 2026 | 156.8% |
| April 13, 2026 | 146.2% |
| April 10, 2026 | 164.9% |
| April 09, 2026 | 151.3% |
| April 08, 2026 | 181.6% |
| April 07, 2026 | 174.0% |
| April 06, 2026 | 164.1% |
| April 02, 2026 | 126.3% |
| April 01, 2026 | 131.0% |
| March 31, 2026 | 112.9% |
| March 30, 2026 | 78.40% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Precision BioSciences, Inc. | 29.43% |
| Black Diamond Therapeutics, Inc. | -23.39% |
| Agenus, Inc. | -43.96% |
| Amgen, Inc. | 22.39% |
| BioCryst Pharmaceuticals, Inc. | -25.02% |